QUAISAR ENGINE
LIVE

Serial Number

97546259

Owner

ROIVANT SCIENCES GMBH

Attorney

Joyce M. Ferraro

Filing Date

Aug 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

QUAISAR ENGINE Trademark

Serial Number: 97546259 • Registration: 7954320

QUAISAR ENGINE is a trademark filed by ROIVANT SCIENCES GMBH on August 12, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ROIVANT SCIENCES GMBH (69 trademarks)

VIADUKTSTRASSE 8
BASEL 4051 , CH

Entity Type: 27

PSIVANT THERAPEUTICS, INC. (4 trademarks)

451 D STREET
BOSTON, MA 02210

Entity Type: 03

ROIVANT DISCOVERY, INC. (3 trademarks)

451 D STREET
BOSTON, MA 02210

Entity Type: 03

Trademark Details

Filing Date

August 12, 2022

Registration Date

September 23, 2025

Published for Opposition

August 5, 2025

Goods & Services

Downloadable and recorded computer software for providing, analyzing and generating reports; downloadable and recorded computer software for data processing; electronic apparatus, electronic equipment, namely, computers and graphic processing units, downloadable and recorded software, downloadable and recorded computer programs and downloadable operating system software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable and recorded computer software for database integration; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for genetic assessment and identification of diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical data and images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 26, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 26, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 26, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 26, 2025 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Mar 11, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Mar 11, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Mar 11, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 16, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 12, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 12, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 15, 2024 GNFN
FINAL REFUSAL E-MAILED
Jun 15, 2024 GNFR
FINAL REFUSAL WRITTEN
Jun 15, 2024 CNFR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 3, 2024 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 16, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 16, 2023 XELR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 4, 2023 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2023 CNRT
ASSIGNED TO EXAMINER
May 31, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2022 NWOS
NEW APPLICATION ENTERED
Aug 16, 2022 NWAP